Canada· CA-DIN-02534223
PRO-SITAGLIPTIN MALATE / METFORMIN HYDROCHLORIDE
A metformin and sitagliptin product containing metformin hydrochloride + sitagliptin (sitagliptin malate), registered in Canada by PRO DOC LIMITEE. The same ATC class is registered in 14 of our 19 countries.
Checked against Health Canada Drug Product Database (Canada) on
Informational only — not a medical device.
Where it is registered
Metformin and sitagliptin is registered in 14 of 19 countries.
Countries holding a registration under ATC A10BD07 (metformin and sitagliptin), each read from that country’s own register.
- This record: Canada, from Health Canada Drug Product Database (Canada)
- 9 of them publish a price we can compare per daily dose
Metformin and sitagliptin · ATC A10BD07
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Health Canada Drug Product Database (Canada)- Active substance
- METFORMIN HYDROCHLORIDE + SITAGLIPTIN (SITAGLIPTIN MALATE)
- Manufacturer
- PRO DOC LIMITEE
- Country
- Canada (CA)
- ATC code
- A10BD07
- ATC class
- Metformin and sitagliptin
- Reimbursed
- Not published by this register
- Source register
- Health Canada Drug Product Database (Canada)
- Last checked
- October 1, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin and sitagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin and sitagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin and sitagliptin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaANSIFORA DUOVipharm S.A., Ożarów Mazowiecki
- SpainDISIMET 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGLaboratorios Alter S.A.
- PolandAnsifora DuoVipharm S.A.
- SwitzerlandJanumet
- NetherlandsEfficib 50 mg/1000 mg, filmomhulde tablettenMerck Sharp & Dohme B.V.
- United StatesJANUMETA-S Medication Solutions
- SwedenEfficib 50 mg/1000 mg Filmdragerad tablettMerck Sharp & Dohme BV
- FinlandBrandasitGenepharm S.A.
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Jamesi, Jansitin Duo
- Belgium · Sitagliptin/Metformin Grindeks, Sitagliptin/Metformin Sandoz
- Bulgaria · Jansitin Duo, Metlinka 50 Mg/1000 Mg
- Cyprus · Diabremet, Jivolar
- Czechia · Ansifora Duo, Asigefort
- Germany · Metformax Combi, Metsunix
- Denmark · Glerova, Sitagliptin/Metformin "sandoz"
- Estonia · Asigefort, Diabremet
- Spain · Disimet, Estequen
- Finland · Brandasit, Sitagliptin/Metformin Glenmark
- France · Sitagliptine/Chlorhydrate De Metformine Micro Labs, Sitagliptine/Chlorhydrate De Metformine Olpha
- United Kingdom (Northern Ireland) · Sitagliptin / Metformin Hydrochloride Macleods, Sitagliptin / Metformin Hydrochloride Macleods Pharma Uk
- Greece · Brandasit, Co-Fineria
- Croatia · Condias Combi, Eprocliv
- Hungary · Ansifora Duo, Asigefort
- Ireland · Sitagliptin And Metformin Hydrochloride Ascend, Sitagliptin/Metformin Clonmel
- Iceland · Aps, Efficib
- Italy · Adiabin, Diesmit
- Liechtenstein · Efficib, Janumet
- Lithuania · Asigefort, Eprocliv
- Latvia · Asigefort, Eprocliv
- Malta · Combodiab Galenicum Health, Diabremet
- Netherlands · Eprocliv, Fordiab
- Norway · Efficib, Janumet
- Poland · Ansifora Duo, Asigefort
- Portugal · Jivolar, Metformina + Sitagliptina Alter
- Romania · Eprocliv, Jamesi
- Sweden · Jivolar, Mifomet
- Slovenia · Eprocliv, Jivolar
- Slovakia · Ansifora Duo, Asigefort
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/c3453e4e-a3a4-4695-a63f-64eec50992a4 GET /v1/drugs/c3453e4e-a3a4-4695-a63f-64eec50992a4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"din": "02534223",
"form": "TABLET",
"class": "Human",
"routes": [
"ORAL"
],
"source": "health_canada_dpd",
"status": "MARKETED",
"atc_raw": "A10BD07",
"schedule": [
"Prescription"
],
"drug_code": "102317",
"strengths": [
"500 MG",
"50 MG"
],
"ahfs_class": null,
"substances": [
"METFORMIN HYDROCHLORIDE",
"SITAGLIPTIN (SITAGLIPTIN MALATE)"
],
"product_categorization": null
}See everything about metformin and sitagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.